Epidemiology of cancer of the uterine cervix: state of the art
DOI:
https://doi.org/10.18597/rcog.489Keywords:
cervical carcinoma, epidemiology, prognosis, human papillomavirusAbstract
This review was aimed at summarising the current state of knowledge about cervical cancer using epidemiological information. Invasive cervical cancer is a potentially preventable disease involving a disproportionate burden in developing countries (83.1% of cases and 85.5% of deaths). Women’s pap smear histories are related to the risk of subsequent cervical cancer. Herpes simplex virus type 2 and other infectious agents have been evaluated in causality studies related to cervical cancer; however, only some types of human papillomavirus have been shown to fulfill the criteria of causality. Clinical factors change survival rates.Author Biographies
Miguel Ángel Castro-Jiménez
Lina María Vera-Cala
Héctor Jaime Posso-Valencia
References
Cannistra SA, Niloff JM. Cancer of the uterine cervix. N Engl J Med 1996;334:1030-8.
Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide, version 2.0. IARC Cancer Base N.º 5. Lyon, France: IARC Press; 2004.
Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ 2001;79:954-62.
Restrepo HE, González J, Roberts E, Litvak J. Epidemiología y control del cáncer de cuello uterino en América Latina y el Caribe. Bol Oficina Sanit Panam 1987;102:578-93.
World Health Organization. Cervical cancer control in developing countries: memorandum from a WHO meeting. Bull World Health Organ 1996;74:345-51.
Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999;91:252-8.
Leavell HR, Clark EG. Preventive medicine for the doctor in his community: an epidemiologic approach. New York: McGraw-Hill Company; 1965. p. 14-38.
Beaglehole R, Bonita R, Kjellstrom T. Epidemiología básica. Washington: OPS; 1994.
Arends MJ, Buckley CH, Wells M. Aetiology, pathogenesis, and pathology of cervical neoplasia. J Clin Pathol 1998;51:96-103.
Chichareon S, Herrero R, Munoz N, Bosch FX, Jacobs MV, Deacon J, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998;90:50-7.
Hill AB. Ambiente y enfermedad: ¿Asociación o causación? Bol Oficina Sanit Panam 1992;113:233-42.
Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S, et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000;163:503-8.
Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357:1831-6.
Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high grade cervical intraepithelial neoplasia. Br J Cancer 1994;69:167-71.
Schiffman MH. New epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 1995;87:1345-7.
Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Desy M, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999;180:1415-23.
Villa LL. Vaccines against papillomavirus infections and disease. Salud Publica Mex 2003;45 suppl 3:S443-8.
Koutsky L A, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347:1645-51.
Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med 2000;248:171-83.
Mueller N. Overview: viral agents and cancer. Environ Health Perspect 1995;103 Suppl 8:259-61.
Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 1997;89:868-73.
Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ 2001;164:1017-25.
Ursin G, Peters RK, Henderson BE, d’Ablaing G III, Monroe KR, Pike MC. Oral contraceptive use and adenocarcinoma of cervix. Lancet 1994;344:1390-4.
Madeleine MM, Daling JR, Schwartz SM, Shera K, McKnight B, Carter JJ, et al. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol Biomarkers Prev 2001;10:171-7.
Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 2001;285:47-51.
Smith JS, Munoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S, et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 2002;185:324-31.
Key TJ, Allen NE, Spencer EA, Travis RC. The effect of diet on risk of cancer. Lancet 2002;360:861-8.
Ziegler RG, Weinstein SJ, Fears TR. Nutritional and genetic inefficiencies in one-carbon metabolism and cervical cancer risk. J Nutr 2002;132:2345S-2349S.
Friedenreich CM. Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomarkers Prev 2001;10:287-301.
Lehtinen M, Koskela P, Jellum E, Bloigu A, Anttila T, Hallmans G, et al. Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries. Am J Epidemiol 2002;156:687-92.
Stuver S, Adami HO. Cervical cancer. En: Adami HO, Hunter DJ, Trichoponlos D, eds. Textbook of Cancer Epidemiology. Oxford: Oxford University Press; 2002. p. 340-58.
Herrero R, Brinton LA, Reeves WC, Brenes MM, Tenorio F, de Britton RC, et al. Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high-risk population. Cancer 1990;65:380-6.
Corral F, Cueva P, Yépez J, Montes E. La baja escolaridad como factor de riesgo en el cáncer de cuello de útero. Bol Of Sanit Panam 1996;121:511-7.
Im SS, Wilczynski SP, Burger RA, Monk BJ. Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion. Clin Cancer Res 2003;9:4145-50.
Lyng H, Sundfor K, Trope C, Rofstad EK. Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy. Clin Cancer Res 2006;6:1104-12.
Milosevic M, Fyles A, Hedley D, Pintilie M, Levin W, Manchul L, et al. Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res 2001;61:6400-5.
Grisaru D, Covens A, Chapman B, Shaw P, Colgan T, Murphy J, et al. Does histology influence prognosis in patients with early-stage cervical carcinoma? Cancer 2001;92:2999-3004.
Alfsen GC, Kristensen GB, Skovlund E, Pettersen EO, Abeler VM. Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix. Cancer 2001;92:2471-83.
Thoms WW, Unger ER, Carisio R, Nisenbaum R, Spann CO, Horowitz IR, et al. Clinical determinants of survival from stage Ib cervical cancer in an inner-city hospital. J Natl Med Assoc 1998;90:303-8.
Wang CJ, Lai CH, Huang HJ, Hong JH, Chou HH, Huang KG, et al. Recurrent cervical carcinoma after primary radical surgery. Am J Obstet Gynecol 1999;181:518-24.
Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;358:781-6.
How to Cite
Downloads
Downloads
Published
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
